Joshua Prince joined the Vistagen team in November 2021 currently serves as our Chief Operating Officer. Mr. Prince brings over 20 years of cross-functional leadership supporting pharmaceutical development and commercialization. Prior to joining the Company, Mr. Prince held multiple positions at CSL Behring, Teva Pharmaceuticals, and AstraZeneca, including North American Lead, Commercial Insight and Analytics, Senior Director of CNS Global Insight, and Director of Forecasting & Performance Analytics. His extensive experience in Psychiatry and Central Nervous System is complemented with experience in Rare Disease, Diabetes, Pain, Cardiovascular, and Immunology. Mr. Prince holds a BS in Mechanical Engineering from the Missouri University of Science and Technology, and an MBA from The Pennsylvania State University.